Lifespan Cancer Institute

Lifespan Cancer Institute
Name	Lifespan Cancer Institute
Location	Providence, Rhode Island
Country	United States
Type	Comprehensive cancer center
Founded	2014

Lifespan Cancer Institute is a comprehensive cancer center based in Providence, Rhode Island, providing integrated oncology care, research, and education across multiple hospitals and outpatient sites. The Institute consolidates clinical programs, multidisciplinary tumor boards, and translational research initiatives to serve patients from New England and beyond. It operates in collaboration with academic partners and national organizations to deliver standard-of-care and experimental therapies.

Overview

The Institute coordinates care among institutions such as Rhode Island Hospital, The Miriam Hospital, Hasbro Children's Hospital, Brown University, Warren Alpert Medical School of Brown University, and regional partners including Miriam Hospital, Roger Williams Medical Center, Saint Joseph Health Services of Rhode Island. Its services span medical oncology, radiation oncology, surgical oncology, palliative care, and survivorship programs aligned with caregivers from Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, and Johns Hopkins Hospital. The Institute participates in cooperative groups and regulatory networks such as National Cancer Institute, American Society of Clinical Oncology, National Comprehensive Cancer Network, American College of Surgeons, and Commission on Cancer.

History and Development

Founded in the mid-2010s, the Institute emerged from consolidation efforts involving Lifespan (health system), Rhode Island Hospital, and The Miriam Hospital to centralize oncology expertise. Early leadership included clinicians and administrators with ties to Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Yale New Haven Hospital, and Moffitt Cancer Center. Expansion milestones featured collaborations with academic partners such as Brown University and national initiatives including National Institutes of Health, Food and Drug Administration, and cooperative trial networks like Alliance for Clinical Trials in Oncology and SWOG Cancer Research Network. Infrastructure growth paralleled capital projects at Kent County Hospital affiliates and ambulatory sites connected to Thundermist Health Center networks.

Clinical Services and Programs

Clinical offerings include subspecialty programs in hematologic malignancies, breast oncology, thoracic oncology, gastrointestinal oncology, genitourinary oncology, neuro-oncology, and pediatric oncology, involving specialists from Massachusetts Eye and Ear, Brigham and Women's Faulkner Hospital, Tufts Medical Center, Boston Children's Hospital, and Hasbro Children's Hospital. Multidisciplinary tumor boards include representation from Radiation Oncology Services, Medical Oncology Divisions linked to Dana-Farber Cancer Institute and surgical teams with experience from Memorial Sloan Kettering Cancer Center and Cleveland Clinic. Supportive services coordinate with organizations such as American Cancer Society, Susan G. Komen Foundation, Leukemia & Lymphoma Society, St. Jude Children's Research Hospital, and community providers including Planned Parenthood affiliates for survivorship care and screening outreach.

Research and Clinical Trials

The Institute conducts investigator-initiated and cooperative group trials in partnership with entities like National Cancer Institute, Department of Veterans Affairs, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group, and industry sponsors including Pfizer, Roche, Merck & Co., AstraZeneca, and Bristol Myers Squibb. Research themes encompass precision oncology, immuno-oncology, translational science, and outcomes research with laboratory collaborations involving Brown University, Warren Alpert Medical School of Brown University, Lankenau Institute for Medical Research, Cold Spring Harbor Laboratory, and consortia such as Project GENIE and The Cancer Genome Atlas. Trials include phase I, phase II, and phase III protocols in targeted therapy, CAR T-cell therapy, checkpoint inhibitors, and radiosensitizers with regulatory oversight tied to Institutional Review Board structures and compliance frameworks influenced by Office for Human Research Protections.

Education and Training

Educational programs involve residency and fellowship rotations affiliated with Warren Alpert Medical School of Brown University, including medical oncology fellowships, radiation oncology training, surgical oncology mentorships, and nurse practitioner education coordinated with Rhode Island College, University of Rhode Island, Bryant University, and continuing medical education through American Society of Clinical Oncology and American Association of Nurse Practitioners. Trainee engagement extends to scholarly activity with presentations at meetings hosted by American Society of Radiation Oncology, American Association for Cancer Research, Society of Surgical Oncology, and regional forums like New England Journal of Medicine-affiliated symposia and grand rounds featuring faculty recruited from Massachusetts General Hospital, Brigham and Women's Hospital, and Yale New Haven Hospital.

Facilities and Affiliations

Clinical sites include adult and pediatric inpatient units at Rhode Island Hospital and outpatient centers located in Providence and suburban campuses, with imaging and interventional services supported by partnerships with Lifespan Health System, Care New England Health System, and ambulatory networks tied to Johnston Health affiliations. The Institute leverages advanced technology sourced from vendors and collaborators including Varian Medical Systems, Elekta AB, Siemens Healthineers, GE Healthcare, and laboratory alliances with Broad Institute-partnered facilities and regional reference laboratories.

Awards and Recognition

The Institute and its affiliated programs have received recognition tied to accreditation and quality metrics from organizations such as Commission on Cancer, American College of Surgeons, U.S. News & World Report, Centers for Medicare & Medicaid Services, and awards or citations in venues hosted by American Society of Clinical Oncology, American Association for Cancer Research, and regional honors connected to Rhode Island Department of Health initiatives. Faculty and investigators have been principal investigators on grants from National Institutes of Health, American Cancer Society, Rapid Cancer Therapeutics, and have published in journals including Journal of Clinical Oncology, The Lancet Oncology, New England Journal of Medicine, Cancer Cell, and Nature Medicine.

Category:Cancer hospitals in the United States